Galectin Therapeutics (GALT) Return on Capital Employed Growth (1y) (2012 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | 68,255.00 |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 2,665.00 |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | 31,429.00 |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 2,503.00 |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | -105.00 |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 2,400.00 |
| 10 | Galectin Therapeutics | 165.77 Mn | 151.67 Mn | - | -19,912.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -19,912.00 |
| Dec 31, 2025 | -59,439.00 |
| Sep 30, 2025 | 131,876.00 |
| Jun 30, 2025 | -157,295.00 |
| Mar 31, 2025 | 30,115.00 |
| Dec 31, 2024 | 74,904.00 |
| Sep 30, 2024 | -92,563.00 |
| Jun 30, 2024 | 4,721.00 |
| Mar 31, 2024 | 16,094.00 |
| Dec 31, 2023 | 18,167.00 |
| Sep 30, 2023 | -8,384.00 |
| Jun 30, 2023 | -18,653.00 |
| Mar 31, 2023 | -30,038.00 |
| Dec 31, 2022 | -48,453.00 |
| Sep 30, 2022 | -17,391.00 |
| Jun 30, 2022 | -5,908.00 |
| Mar 31, 2022 | 136.00 |
| Dec 31, 2021 | -895.00 |
| Sep 30, 2021 | -5,244.00 |
| Jun 30, 2021 | -8,178.00 |
| Mar 31, 2021 | -8,869.00 |
| Dec 31, 2020 | -6,000.00 |
| Sep 30, 2020 | -3,693.00 |
| Jun 30, 2020 | -817.00 |
| Mar 31, 2020 | 12,440.00 |
| Dec 31, 2019 | 14,786.00 |
| Sep 30, 2019 | 11,800.00 |
| Jun 30, 2019 | 18,392.00 |
| Mar 31, 2019 | 52,702.00 |
| Dec 31, 2018 | 44,401.00 |
| Sep 30, 2018 | 34,227.00 |
| Jun 30, 2018 | 625.00 |
| Mar 31, 2018 | -49,782.00 |
| Dec 31, 2017 | -44,415.00 |
| Sep 30, 2017 | -31,776.00 |
| Jun 30, 2017 | -9,233.00 |
| Mar 31, 2017 | -8,289.00 |
| Dec 31, 2016 | -8,759.00 |
| Mar 31, 2016 | -4,924.00 |
| Dec 31, 2015 | -3,526.00 |
| Mar 31, 2015 | 877.00 |
| Dec 31, 2014 | 10,241.00 |
| Sep 30, 2014 | 15,215.00 |
| Jun 30, 2014 | 19,052.00 |
| Mar 31, 2014 | 9,858.00 |
| Dec 31, 2013 | -4,273.00 |
| Sep 30, 2013 | -9,739.00 |
| Jun 30, 2013 | -15,462.00 |
| Mar 31, 2013 | -4,565.00 |
| Dec 31, 2012 | 8,914.00 |
| Sep 30, 2012 | 1,312.00 |